ACUR insider buying and SEC filings, explained
Acura Pharmaceuticals, Inc. · CIK 786947
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- NY
- Fiscal year end
- Dec 31
- Former names
- HALSEY DRUG CO INC/NEW
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
No insider purchases or sales filed in the last 12 months.
3 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Nov 3, 2026, 8:20 AM ET 8-K | Material agreement (Item 1.01) Acquisition or disposal completed (Item 2.01) New debt or obligation (Item 2.03) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow ACUR in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.